TSE:BHC Bausch Health Companies (BHC) Stock Price, News & Analysis C$8.04 -0.13 (-1.59%) As of 09/23/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and Trends About Bausch Health Companies Stock (TSE:BHC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BHC alerts:Sign Up Key Stats Today's RangeC$8.00▼C$8.3550-Day RangeC$6.25▼C$9.6552-Week RangeC$6.10▼C$11.08Volume969,244 shsAverage Volume547,462 shsMarket CapitalizationC$3.01 billionP/E RatioN/ADividend Yield0.76%Price TargetN/AConsensus RatingHold Company Overview Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. Read More Bausch Health Companies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreBHC MarketRank™: Bausch Health Companies scored higher than 12% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingBausch Health Companies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageBausch Health Companies has only been the subject of 1 research reports in the past 90 days.Read more about Bausch Health Companies' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Bausch Health Companies is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bausch Health Companies is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBausch Health Companies has a PEG Ratio of 0.21. PEG Ratios below 1 indicate that a company could be undervalued. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for BHC. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldBausch Health Companies has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBausch Health Companies does not have a long track record of dividend growth.Read more about Bausch Health Companies' dividend. News and Social Media1.4 / 5News SentimentN/A News SentimentBausch Health Companies has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Healthcare companies.Search InterestOnly 6 people have searched for BHC on MarketBeat in the last 30 days. This is a decrease of -45% compared to the previous 30 days. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Bausch Health Companies insiders have not sold or bought any company stock.Percentage Held by Insiders11.28% of the stock of Bausch Health Companies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions9.66% of the stock of Bausch Health Companies is held by institutions.Read more about Bausch Health Companies' insider trading history. Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BHC Stock News HeadlinesBausch Health (BHC) Expands Probiotic Skincare Bet To Six New MarketsSeptember 16, 2026 | insidermonkey.comBausch Health Expands Collaboration With Belgian Dermatology Company YunSeptember 8, 2026 | finance.yahoo.comHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its valuation has doubled since the announcement, with some estimates putting the company's worth near 3 trillion dollars by IPO day. Google, Amazon, Nvidia and Microsoft have all taken stakes, while Goldman Sachs, Morgan Stanley and JPMorgan are competing for private shares. Anthropic's annualized revenue reportedly grew 80 times in the first quarter alone. See how investors are positioning ahead of this closely watched IPO.September 24 at 1:00 AM | Weiss Ratings (Ad)Bausch Health Makes Fraxel FTX System Available in AustraliaSeptember 1, 2026 | finance.yahoo.comWhy Bausch Health (BHC) is a top momentum stock for the long termAugust 11, 2026 | msn.comBausch Health (BHC) Q2 2026 Earnings Call TranscriptAugust 7, 2026 | finance.yahoo.comBausch Health Chief Executive Thomas Appio Appointed to Bausch + Lomb BoardAugust 7, 2026 | finance.yahoo.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY), Ultragenyx Pharmaceutical (RARE) and Bausch Health Companies (BHC)August 1, 2026 | theglobeandmail.comSee More Headlines BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Companies' stock was trading at C$9.53 at the start of the year. Since then, BHC stock has decreased by 15.6% and is now trading at C$8.04. How were Bausch Health Companies' earnings last quarter? Bausch Health Companies Inc. (TSE:BHC) announced its earnings results on Wednesday, July, 29th. The company reported $1.79 earnings per share for the quarter. The firm earned $4.05 billion during the quarter. Bausch Health Companies had a negative net margin of 12.02% and a positive trailing twelve-month return on equity of 87.57%. How do I buy shares of Bausch Health Companies? Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Bausch Health Companies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Meta Platforms (META), Advanced Micro Devices (AMD), Enbridge (ENB), Shopify (SHOP), NVIDIA (NVDA) and Ford Motor (F). Company Calendar Last Earnings7/29/2026Today9/24/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolTSE:BHC CIKN/A Webwww.bauschhealth.com Phone514-744-6792FaxN/AEmployees20,300Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($2.94) Trailing P/E RatioN/A Forward P/E Ratio1.45 P/E Growth0.21Net Income-C$125.65 million Net Margins-12.02% Pretax MarginN/A Return on Equity87.57% Return on Assets4.16% Debt Debt-to-Equity Ratio-1,173.29 Current Ratio1.44 Quick Ratio0.58 Sales & Book Value Annual SalesC$10.85 billion Price / Sales0.28 Cash FlowC$1.04 per share Price / Cash Flow7.76 Book ValueC($2.14) per share Price / Book-3.76Miscellaneous Outstanding Shares373,991,000Free FloatN/AMarket CapC$3.01 billion OptionableNot Optionable Beta0.71 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (TSE:BHC) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredOn October 7th, your “safest” assets are at riskJeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...Brownstone Research | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
